Clindamycin bioavailability and pharmacokinetics following oral administration of clindamycin hydrochloride capsules in dogs

Veterinary Journal

Volumn 170, Issue 3, 2005, Pages 339-345

  Batzias, Georgios C ^a   Delis, Georgios A ^a   Athanasiou, Labrina V ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b Veterin SA   (Greece)

Author keywords

Bioavailability; Capsules; Clindamycin; Dogs; Pharmacokinetics

Indexed keywords

CLINDAMYCIN; VETERINARY DRUG;

ARTICLE; BODY FLUID; DISTRIBUTION VOLUME; DOG; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG TISSUE LEVEL; MALE; MICROORGANISM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STEADY STATE;

ABSORPTION; ADMINISTRATION, ORAL; ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CAPSULES; CLINDAMYCIN; DOGS; INJECTIONS, INTRAVENOUS; MALE; MICROBIAL SENSITIVITY TESTS; RANDOM ALLOCATION;

BACTERIA (MICROORGANISMS); CANIS FAMILIARIS;

EID: 27844478779     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2004.06.007     Document Type: Article

References (35)

1. A. Athamna M. Athamna B. Medlej D.J. Bast E. Rubinstein In vitro post-antibiotic effect of fluoroquinolones, macrolides, β-lactams, tetracyclines, vancomycin, clindamycin, linezolid, chloramphenicol, quinupristin/dalfopristin and rifampicin on Bacillus anthracis Journal of Antimicrobial Chemotherapy 53 2004 609-615
2. G.C. Batzias G.A. Delis M. Koutsoviti-Papadopoulou A new HPLC/UV method for the determination of clindamycin in dog blood serum Journal of Pharmaceutical and Biomedical Analysis 35 2004 545-554
3. J.N. Berg C.M. Scanlan G.M. Buening W.H. Fales D.A. Schmidt J.C. Wilson Clinical models for anaerobic bacterial infections in dogs and their use in testing the efficacy of clindamycin and lincomycin American Journal of Veterinary Research 45 1984 1299-1306
4. Bishop Drugs used in the treatment of bacterial, fungal, viral, and protozoal infections The Veterinary Formulary fifth ed 2001 Pharmaceutical Press London 135-218
5. P.B. Bloom E.J. Rosser Efficacy of once-daily clindamycin hydrochloride in the treatment of superficial bacterial pyoderma in dogs Journal of the American Animal Hospital Association 37 2001 537-542
6. D.M. Boothe Anaerobic infections in small animals Veterinary Medicine 2 1990 330-347
7. T.D. Braden C.A. Johnson C.L. Gabel G.A. Lott D.D. Caywood Posologic evaluation of clindamycin, using a canine model of posttraumatic osteomyelitis American Journal of Veterinary Research 48 1987 1101-1105
8. S.A. Brown T.M. Dieringer R.P. Hunter M.J. Zaya Oral clindamycin disposition after single and multiple doses in normal cats Journal of Veterinary Pharmacology and Therapeutics 12 1989 209-216
9. S.A. Brown M.J. Zaya T.M. Dieringer R.P. Hunter J.L. Nappier G.A. Hoffman R.E. Hornish F.S. Yein Tissue concentrations of clindamycin after multiple oral doses in normal cats Journal of Veterinary Pharmacology and Therapeutics 13 1990 270-277
10. S.C. Budsberg D.T. Kemp N. Wolski Pharmacokinetics of clindamycin phosphate in dogs after single intravenous and intramuscular administrations American Journal of Veterinary Research 53 1992 2333-2336
11. W.A. Craig Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men Clinical Infectious Diseases 26 1998 1-12
12. W.A. Craig S. Gudmundsson Postantibiotic effect In: V. Lorian (Ed.), Antibiotics in Laboratory Medicine fourth ed. 1996 Williams & Wilkins Baltimore 296-329
13. S.W. Dow Management of anaerobic infections The Veterinary Clinics of North America - Small Animal Practice 18 1988 1167-1182
14. G. Gatti M. Malena R. Casazza M. Borin M. Bassetti M. Cruciani Penetration of clindamycin and its metabolite, N-demethylclindamycin into cerebrospinal fluid following intravenous infusion of clindamycin phosphate in patients with AIDS Antimicrobial Agents and Chemotherapy 42 1998 3014-3017
15. M. Gibaldi D. Perrier Absorption kinetics and bioavailability In: Pharmacokinetics 1982 Marcel Dekker Inc. New York 145-198
16. M. Gibaldi D. Perrier Noncompartmental analysis based on statistical moment theory In: Pharmacokinetics 1982 Marcel Dekker Inc. New York 409-424
17. R.G. Harvey W.C. Noble E.A. Ferguson A comparison of lincomycin hydrochloride and clindamycin hydrochloride in the treatment of superficial pyoderma in dogs The Veterinary Record 132 1993 351-353
18. M.E. Klepser D.P. Nicolau R. Quintiliani C.H. Nightingale Bactericidal activity of low-dose clindamycin administered at 8- and 12-hour intervals against Staphylococcus aureus, Streptococcus pneumoniae, and Bacteroides fragilis Antimicrobial Agents and Chemotherapy 41 1997 630-635
19. K. Lamp M.K. Lacy C. Freeman Metronidazole, clindamycin and streptogramin pharmacodynamics In: C.H. Nightingale T. Murakawa P.G. (Eds.), Ambrose Antimicrobial Pharmacodynamics in Theory and Clinical Practice 2002 Marcel Dekker Inc. New York 227-231
20. E. Lavy M. Shem-Tov A. Orbach Oral absorption, bioavailability and tolerance study of clindamycin gel 3% in dogs Journal of Veterinary Pharmacology and Therapeutics 23 suppl. 1, on CD Rom 2000
21. E. Lavy G. Ziv M. Shem-Tov A. Glickman A. Dey Pharmacokinetics of clindamycin HCl administered intravenously, intramuscularly and subcutaneously to dogs Journal of Veterinary Pharmacology and Therapeutics 22 1999 261-265
22. R.E. Lewis M.E. Klepser E.J. Ernst B.C. Lund D.J. Biedenbach R.N. Jones Evaluation of low-dose, extended-interval clindamycin regimens against Staphylococcus aureus and Streptococcus pneumoniae using a dynamic in vitro model of infection Antimicrobial Agents and Chemotherapy 43 1999 2005-2009
23. D.S. Lindsay N.S. Rippey R.A. Cole L.C. Parsons J.P. Dubey R.R. Tidwell B.L. Blagburn Examination of the activities of 43 chemotherapeutic agents against Neospora caninum tachyzoites in cultured cells American Journal of Veterinary Research 55 1994 976-981
24. J.D. Littlewood K.H. Lakhani S. Paterson J.L.N. Wood N. Chanter Clindamycin hydrochloride and clavulanate-amoxycillin in the treatment of canine superficial pyoderma The Veterinary Record 144 1999 662-665
25. L. Ordeix A. Lloret D. Fondevila J.B. Dubey L. Ferrer A. Fondati Cutaneous neosporosis during treatment of pemphigus foliaceus in a dog Journal of the American Animal Hospital Association 38 2002 415-419
26. G.A. Pankuch M.R. Jacobs P.C. Appelbaum Susceptibilities of 428 gram-positive and -negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin Antimicrobial Agents and Chemotherapy 37 1993 1649-1654
27. J.D. Panzer D.C. Brown W.L. Epstein R.L. Lipson H.W. Mahaffey W.H. Atkinson Clindamycin levels in various body tissues and fluids Journal of Clinical Pharmacology-New Drugs 12 1972 259-262
28. E.R. Pfefferkorn S.E. Borotz Comparison of mutants of Toxoplasma gondii selected for resistance to azithromycin, spiramycin, or clindamycin Antimicrobial Agents and Chemotherapy 38 1994 31-37
29. J.F. Prescott Lincosamides, macrolides and pleuromutilins In: J.F. Prescott J.D. Baggot R.D. Walker (Eds.), Antimicrobial Therapy in Veterinary Medicine third ed. 2000 Iowa State University Press Ames 229-262
30. E. Sarkiala C. Harvey Systemic antimicrobials in the treatment of periodontitis in dogs Seminars in Veterinary Medicine and Surgery-Small Animal 8 1993 197-203
31. R. Schaumann G. Ackermann B. Pless M.C. Claros E.J.C. Goldstein A.C. Rodloff In vitro activities of fourteen antimicrobial agents against obligately anaerobic bacteria International Journal of Antimicrobial Agents 16 2000 225-232
32. D.W. Scott K.E. Beningo W.H. Miller Jr. E. Rothstein Efficacy of clindamycin hydrochloride capsules for the treatment of deep pyoderma due to Staphylococcus intermedius infection in dogs Canadian Veterinary Journal 39 1998 753-756
33. B. Vogelman S. Gudmundsson J.D. Turnidge J. Leggett W.A. Craig In vivo postantibiotic effect in a thigh infection in neutropenic mice Journal of Infectious Diseases 157 1988 287-298
34. M.A. Wynalda J.M. Hutzler M.D. Koets T. Podoll L.C. Wienkers In vitro metabolism of clindamycin in human liver and intestinal microsomes Drug Metabolism and Disposition 31 2003 878-887
35. I.B. Xue P.G. Davey G. Phillips Variation in postantibiotic effect of clindamycin against clinical isolates of Staphylococcus aureus and implications for dosing of patients with osteomyelitis Antimicrobial Agents and Chemotherapy 40 1996 1403-1407